Attenuation of Isoproterenol Induced Cardiotoxicity by Moringa oleifera Seeds
Simran C. Chaudhary1, Pallavi A. Patil1*, Hennu Dhar2, Udaykumar S. Patil3,
Abhijit L. Patil4, Vaibhavi N. Garge1
1Department of Pharmacology, Bharati Vidyapeeth’s College of Pharmacy, C.B.D. Belapur,
Navi Mumbai, 400614.
2Department of Pharmacology, FMHS Sgt University, Haryana, 122505.
3Department of Pharmaceutics, Bharati Vidyapeeth’s College of Pharmacy, Kolhapur, 416013.
4Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth Vadgaon, Maharashtra, 416112.
*Corresponding Author E-mail: sbvp2023@gmail.com
ABSTRACT:
Objective: To understand the cardioprotective effect of Moringa oleifera (MO) seed powder using isoproterenol induced cardiotoxicity in albino rats of wistar strain. Materials and Methods: Hydroalcoholic extract of MO (HAMO) seeds was prepared by soxhlet method and used for the study. After phytochemical analysis, the extract was evaluated for in vivo study. Six rats were grouped. Group 1 as vehicle, group 2 as disease control, group 3 as standard, group 4 and 5 as low and high dose of hydroalcoholic extract of MO (200mg/kg, 400mg/kg) respectively. ECG parameters, cardiac markers and oxidative stress were assessed. Results: 4% yield was obtained. ST segment elevation and increased heart rate by Isoproterenol was treated by hydroalcoholic extract of MO seeds. CK-MB, LDH levels were also restored in treatment groups as compared to disease control. The endogenous antioxidant enzymes catalase and GSH activity increased in treatment groups whereas lipid peroxidation was decreased significantly. The HAMO (400mg/kg) showed better cardioprotective activity as equivalent to Terminalia arjuna tablets which was used as standard. In histology findings, HAMO (400mg/kg) showed decrease in necrosis as compared to disease control. Conclusion: The HAMO (400mg/kg) has proven to attenuate cardiotoxicity induced by Isoproterenol, confirmed by ECG, cardiac markers and histopathological findings.
KEYWORDS: Cardioprotective, Moringa oleifera, Electrocardiogram, Isoproterenol, Myocardial infarction.
INTRODUCTION:
Cardiovascular diseases include cardiac and vascular disorders (CVDs). It is the leading cause of death worldwide, CVDs have killed 32% of the global population (17.9 million people), with heart attacks and strokes accounting for 85% of all deaths1. Myocardial cell loss and necrosis can result from the myocardium receiving insufficient oxygen for an extended period of time2. “Toxicity that affects the heart” is the definition of cardiotoxicity given by National Cancer Institute.
This definition includes a direct effect of the drug on the heart but also an indirect effect due to enhancement of haemodynamic flow alterations or due to thrombotic events3. Isoproterenol (ISO) induced cardiotoxicity is the chemical induced and most commonly used for acute and chronic cardiac injury. If given in fractionated doses, ISP causes progressive cardiac damage; however, larger doses can cause acute damage4,5. ISO is synthetic sympathomimetic drug nonselective β‐adrenergic agonist. For induction of MI, it is administered in high dose (85mg/kg-340 mg/kg) subcutaneously6. It produces cytotoxic free radicals in myocytes, which induce apoptosis and necrosis upon auto‐oxidation7. It has ability to produce endogenous and exogenous free radicals which leads to generation of oxidative stress due to excessive accumulation of catecholamines in the body. These free radicals generated will initiate peroxidation of polyunsaturated fatty acids (PUFAs) progressing into both structural and functional myocardial damage. Hence, it is used as a standard inducing agent to study the protective and the preventive effects against myocardial ischemia, MI and cardiac fibrosis8.
In the ancient Indian medical system of Ayurveda, Moringa oleifera (MO) plays a significant role. It is a member of the Moringaceae family, commonly known as "Sahajan or Drumstick". Seeds of MO contain important bio-active compounds like flavonoids, glucosinolates, isothiocyanates and thiocarbamates. The compounds have ability to regenerate membrane potential by quenching ROS9,10. Previous studies have mentioned the presence of flavonoids kaempferol, quercetin, moringin, ß-sitosterol in MO seeds11,12. Since the flavonoids are present in MO seeds. Hence, the present study aims to reveal the cardioprotective activity for the same.
The dried seeds of MO were procured from S.V. Ayurvedic Bhandar, Navi Mumbai and identified by Alarsin Pharmaceuticals, Mumbai under voucher specimen number (PG/2022/015). Seeds were pulverized, extracted using hydroalcohol, defatted using petroleum ether and stored at 40°C and stored in desiccator.
The extract was subjected to preliminary phytochemical test for presence of various phytochemicals in compliance with Kokate and Harborne13,14.
Forty-two adult male albino wistar rats of 150-200 grams were housed in sterile polypropylene cages in 12-hour light/ 12-hour dark cycle, temperature 22±3°C, humidity 50%-60%. They were fed with standard food pellet and water ad libitum. Following the guidelines of the Committee for Control and Supervision of Experiments on Animals (CCSEA), New Delhi, India, the Institutional Animal Ethics Committee (IAEC) at Bharati Vidyapeeth’s College of Pharmacy approved the experimental protocol under reference BVCP/IAEC/09/2022.
Animals were acclimatized for 7 days then randomized in five groups with six animals per group. All drugs were administered orally by gavage as pretreatment for 21 days except disease control, whereas Isoproterenol (ISP) was injected subcutaneously in dose 85mg/kg15 for 2 consecutive days i.e., on day 20 and 21 in all the groups except control. The treatment given were as follows: Group I Vehicle control (1% CMC, p.o.)16, Group II Disease control ISP injection (85 mg/kg body weight, s.c.), Group III Standard treatment Terminalia arjuna tablet (250mg/kg body weight, p.o.), Group IV low dose of hydroalcoholic extract of Moringa oleifera (HAMO) (200mg/kg body weight, p.o.), Group V high dose of HAMO (400mg/kg body weight, p.o.).
Basal ECG recording was performed on 24 hrs after second injection of ISO. ECG was performed by Biopac Student Lab (Biopac 4.0.2) data acquisition unit for MP35. Biopac electrode lead set×2 and disposable 3 vinyl electrodes per rat. The data was analyzed later after recording17,18.
After 21 days of treatment, blood was collected from retro orbital plexus under Isoflurane anesthesia in sterile centrifuge tube. The serum was separated for estimation of biochemical parameters: - Total Cholesterol (TC), Serum Triglycerides (TG), High density lipoprotein (HDL-C), Creatine kinase-myoglobin binding (CK-MB), Lactate dehydrogenase (LDH), Alanine aminotransferase (ALT), Aspartate aminotransferase (AST) using ERBA Diagnostic Kit. Low density lipoprotein (LDL-C) was calculated using below mentioned formula 19.
After blood collection, animals were sacrificed using CO2 overdose and heart tissues were isolated, washed with ice-cold saline, fixed with 10% formalin and embedded on paraffin wax. 5-mm paraffin section was cut, stained with hematoxylin and eosin (H&E), and seen under a light microscope[20]. 10% homogenate of tissue was prepared in phosphate buffer solution (pH 7.4)21. All the biochemical estimation of reduced glutathione (GSH)22, catalase (CAT)23, and malondialdehyde (MDA)24 were performed using standard procedures.
The data sets were analyzed using one-way ANOVA followed by Dunnett’s test and expressed as mean ± standard error mean (SEM). The p value of <0.05 was considered as significant. All the statistics was performed using GraphPad Prism, version 9.
The preliminary phytochemical of HAMO has shown presence of carbohydrates, alkaloids, glycosides, tannins, flavonoids, phenols, triterpenoids, saponins (Table 1).
There was significant (p<0.0001) decrease in QRS complex and significant (p<0.001) increase in ST segment elevation time and heart rate in disease control when compared to vehicle control. Whereas QRS complex significantly (p<0.001, p<0.05) increased in standard Terminalia Arjuna tablets (250 mg/kg), HAMO (200 mg/kg, 400 mg/kg). The ST segment elevation time and heart rate significantly (p<0.001, p<0.05) decreased in standard and HAMO (200 mg/kg, 400 mg/kg) (Figure 1).
Serum levels of TC, TG and LDL-C of disease control increased significantly (p<0.0001) increased when compared to the vehicle control. Whereas, HDL-C levels of disease control decreased (p<0.0001) as compared to vehicle control. In groups previously treated with standard Terminalia Arjuna tablets (250 mg/kg), HAMO (200 mg/kg, 400 mg/kg) the significant change in lipid profile was seen when compared to disease control (Table 2).
Table 1: Phytochemical screening of HAMO
Phytochemical Test |
Carbohydrates |
Alkaloids |
Glycosides |
Tannins |
Flavonoids |
Phenols |
Triterpenoids |
Saponins |
Proteins |
Results |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
- |
Figure 1: Effect of HAMO on A) QRS complex, B) ST segment elevation and C) Heart rate
Values are expressed as mean ± SEM (n=6). #p< 0.0001 when compared with vehicle control, ***p<0.001, **p <0.05 when compared with Disease control. Data was analysed by one way ANOVA followed by Dunnett’s test.
Table 2 - Effect of HAMO on TC, TG, HDL-C and LDL-C
Groups |
Total cholesterol (mg/dl) |
Triglycerides (mg/dl) |
HDL-C (mg/dl) |
LDL-C (mg/dl) |
|
1 |
Vehicle Control |
82.99 ± 2.647 |
88.72 ± 3.279 |
29.10 ± 1.881 |
36.87 ± 3.224 |
2 |
Disease Control |
114.1 ± 3.439# |
118.7 ± 3.121# |
9.865 ± 1.131# |
80.51 ± 3.316# |
3 |
Standard Treatment |
91.87 ± 2.589*** |
99.25 ± 2.343*** |
21.75 ± 1.233*** |
50.27 ± 3.674*** |
4 |
Low dose HAMO |
99.47 ± 1.861** |
101.8 ± 3.023*** |
17.32 ± 2.112** |
61.79 ± 3.561** |
5 |
High dose HAMO |
92.72 ± 2.838*** |
99.22 ± 1.809*** |
21.18 ± 1.593*** |
51.69 ± 3.587*** |
Values are expressed as mean ± SEM (n=6). #p< 0.0001 when compared with vehicle control, ***p<0.001, **p < 0.05 when compared with disease control. Data was analysed by one way ANOVA followed by Dunnett’s test.
The levels of CK-MB, LDH, ALT, AST significantly increased (p<0.0001) in disease control as compared to vehicle control. In pretreated groups the levels of markers were decreased. The significant decrease (p<0.001) was seen in standard Terminalia Arjuna tablets (250 mg/kg), HAMO (400mg/kg), whereas, group pretreated with HAMO (200mg/kg), significant (p<0.05) decrease in cardiac markers was observed when compared to disease control (Figure 2).
Figure 2 - Effect of HAMO on A) CK-MB, B) LDH, C) ALT and D) AST
Values are expressed as mean ± SEM (n=6). #p< 0.0001 when compared with vehicle control, ***p<0.001, **p<0.05 when compared with disease control. Data was analysed by one way ANOVA followed by Dunnett’s test.
Table 3: Effect of HAMO on MDA, GSH and Catalase
Sr. No. |
Groups |
MDA (μ mol/g wt of heart tissue) |
GSH (μ mol/g wt of heart tissue) |
Catalase (μ mol/g wt of heart tissue) |
I. |
Vehicle Control |
2.750 ± 0.2444 |
3.824 ± 0.2305 |
79.73 ± 2.893 |
II. |
Disease Control |
5.897 ± 0.2441 # |
1.216 ± 0.1282 # |
44.21 ± 1.143# |
III. |
Standard Treatment |
3.768 ± 0.2280*** |
2.680 ± 0.2075*** |
64.69 ± 1.756*** |
IV. |
Low dose HAMO |
4.735 ± 0.4159** |
2.002 ± 0.2031** |
53.02 ± 2.038** |
v. |
High dose HAMO |
3.907 ± 0.3159*** |
2.493 ± 0.2396*** |
65.08 ± 1.072*** |
Values are expressed as mean ± SEM (n=6). #p< 0.0001 when compared with vehicle control, ***p<0.001, **p < 0.05 when compared with disease control. Data was analysed by one way ANOVA followed by Dunnett’s test.
The disease control group has shown significant (p<0.0001) increase in MDA levels whereas, significant decrease (p<0.0001) was observed in GSH and catalase levels in comparison to vehicle control. In contrast groups pretreated with standard Terminalia arjuna tablets (250 mg/kg body weight), HAMO (200 mg/kg, 400mg/kg body weight) have significantly (p<0.001, p<0.05) decreased the levels of MDA, whereas, the levels of catalase and GSH significantly (p<0.001, p<0.05) increased in pretreated groups in comparison to disease control (Table 3).
In vehicle control (Figure 5A) no abnormalities were detected. Moderately multifocal, mild to moderate degree necrosis and loss of sarcoplasm with minimal to mild degree mononuclear cell infiltration was observed in disease control. Prominent changes in endocardium and papillary muscles were also seen (Figure 5B). Although histological damage decreased in treatment groups in comparison to disease control. In standard treatment Terminalia arjuna tablets (250mg/kg) sporadic foci of minimal degree and mononuclear cell infiltration in the myocardium was seen (Figure 5C). Mildly multifocal, mild degree necrosis and loss of sarcoplasm with mild degree mononuclear cell infiltration was observed in HAMO (200mg/kg) (Figure 5D). The HAMO (400mg/kg) group has shown minimal multifocal, mild degree of necrosis and loss of sarcoplasm with minimal degree mononuclear cell infiltration (Figure 5E).
Figure 5: Histology of ischemic heart by hematoxylin-eosin stain; A) Vehicle control, B) Disease control, C) Standard treatment Terminalia Arjuna tablets (250 mg/kg), D) Low dose HAMO (200 mg/kg), E) High dose HAMO (400 mg/kg)
The present study revealed that Moringa oleifera seeds can act as cardioprotective by attenuating Isoproterenol induced acute myocardial infarction.
Our data demonstrated that HAMO mainly contains flavonoids, phenols and tannins which could be responsible to produce cardioprotective effect. MO seeds mainly contains flavonoids like kaempferol, quercetin, moringin, ß-sitosterol 11. Quercetin has ability to act as cardioprotective due to its antioxidant and antiplatelet properties25. Kaempferol improves cardiac function and structure by preventing apoptosis, oxidative damage, inflammation, fibrosis, calcium regulation, and other heart diseases26–28.
In current investigation, HAMO exerted cardioprotective action by reducing the levels of serum lipids, cardiac marker enzymes and lipid peroxidation and by restoring endogenous antioxidant enzymes. In ECG, the present study revealed elevation in ST segment, increased heart rate and low QRS complex in disease control, which are diagnostic features of acute myocardial infarction which occurs due to auto oxidation 29–31. Alterations to the ECG, including an elevation of the ST segment were prevented in treatment with Terminalia arjuna tablets and HAMO, 33,32.
The lipids affect the composition, structure, and stability of cellular membranes, which significantly impacts development of atherosclerosis and other cardiovascular diseases [34]. It was found that disease control had high levels of serum TC, TG and LDL-C and low level of HDL-C[35]. HDL-C facilitates the transfer of cholesterol from peripheral tissue to the liver, where it is catabolized and expelled from the body, and inhibits the uptake of LDL-C by the arterial wall 36. While administration of Terminalia arjuna tablets and HAMO in treatment groups restored normal lipid levels.
Cardiac markers like CK-MB, LDH, ALT and AST. CK-MB isoenzyme activity is mostly seen in cardiac tissues makes it a valuable marker for the early detection of MI [37]. When cell membranes become more permeable or break, cytosolic enzymes such as CK-MB, LDH, AST, and ALT leaks into the blood stream. The concentrations of these cellular enzymes in the serum are reflection of changes to plasma membrane permeability and proportional to necrosis of cell, in response to β-adrenergic stimulation [38–40]. Pretreatment with of Terminalia arjuna tablets and HAMO reduced the elevated levels, indicating that HAMO restricts leakage of these enzymes and maintains cell permeability.
The physiological balance between the free radical production and body's anti-oxidative defence mechanism is altered in ISO induced MI, leading to myocardial oxidative stress 41. In this study the endogenous antioxidants GSH and catalase activity decreased in disease control in comparison to vehicle control. Pretreatment with of Terminalia arjuna tablets and HAMO improved the activity of endogenous antioxidants. The levels of MDA were increased in disease control as it is ending product of lipid peroxidation45. Heart tissue appears to be more vulnerable to oxidative damage due to increased lipid peroxidation as the first stage of the pathophysiology in MI. The MDA levels were significantly decreased in treatment groups.
Histopathology of heart tissue of vehicle control illustrated no changes in myocardial cell integrity. Disease group has shown moderate necrosis and loss of sarcoplasm. Whereas, pretreatment with HAMO (400mg/kg) has shown similar results to that of standard. Minimal degree of mononuclear cell infiltration was observed in standard whereas, minimally multifocal with minimal degree of mononuclear cell infiltration was seen in HAMO (400mg/kg).
The ECG, biochemical and histopathology findings confirm HAMO has cardioprotective activity. This could be due to antioxidant activity caused by polyphenols, flavonoids present in the MO seeds. We conclude that MO seeds can be used as cardioprotective by preventing myocardium damage caused by oxidative stress. Although the exact mechanism is not known. Further studies should be carried out to understand the exact mechanism.
The authors are grateful to The Principal, Dr. Vilasrao Kadam of Bharati Vidyapeeth’s College of Pharmacy, C.B.D Belapur for providing facilities to carry out the present work.
ETHICS COMMITTEE APPROVAL:
The protocol was approved by Institutional Animal Ethics Committee (IAEC), Bharati Vidyapeeth’s College of Pharmacy (BVCP/IAEC/09/2022).
1. Joseph T Dipiro, Gary C. Yee, L. Michael Posey. A pathophysiological approach of pharmacotherapy. 7th ed. 2008.
2. Rasuli B, Kuok Y-J. Myocardial infarction. Radiopaedia.org, Radiopaedia.org; 2011. https://doi.org/10.53347/rID-14484.
3. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic Health Conditions in Adult Survivors of Childhood Cancer. New England Journal of Medicine. 2006; 355: 1572–82. https://doi.org/10.1056/NEJMsa060185.
4. Hasenfuss G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res. 1998; 39: 60–76. https://doi.org/10.1016/S0008-6363(98)00110-2.
5. Oudit GY, Crackower MA, Eriksson U, Sarao R, Kozieradzki I, Sasaki T, et al. Phosphoinositide 3-Kinase γ–Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure. Circulation. 2003;108:2147–52. https://doi.org/10.1161/01.CIR.0000091403.62293.2B.
6. Hosseini A, Rajabian A, Sobhanifar M-A, Alavi MS, Taghipour Z, Hasanpour M, et al. Attenuation of isoprenaline-induced myocardial infarction by Rheum turkestanicum. Biomedicine and Pharmacotherapy. 2022; 148: 112775. https://doi.org/10.1016/j.biopha.2022.112775.
7. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989; 65: 657–70. https://doi.org/10.1161/01.RES.65.3.657.
8. Kondo T, Ogawa Y, Sugiyama S, Ito T, Satake T, Ozawa T. Mechanism of isoproterenol induced myocardial damage. Cardiovasc Res. 1987; 21: 248–54. https://doi.org/10.1093/cvr/21.4.248.
9. Ashok Kumar N, Pari L. Antioxidant Action of Moringa oleifera Lam. (Drumstick) Against Antitubercular Drugs Induced Lipid Peroxidation in Rats. J Med Food. 2003; 6: 255–9. https://doi.org/10.1089/10966200360716670.
10. Indurwade NH, Chaudhari SB, Maskare RG, Bandre JU, Bhivgade N. Comparative Study of Antimicrobial and Antioxidant Activity between Seeds and Leaves of Crude Drug Moringa oleifera. Res J Pharm Technol. 2019; 12: 1843. https://doi.org/10.5958/0974-360X.2019.00308.1.
11. Alia F, Putri M, Anggraeni N, Syamsunarno MRAA. The Potency of Moringa oleifera Lam. as Protective Agent in Cardiac Damage and Vascular Dysfunction. Front Pharmacol. 2022; 12. https://doi.org/10.3389/fphar.2021.724439.
12. Hanafi A, Fadholly A, Utomo B, Sudjarwo SA, Yunus M, Hariadi M, et al. Effects of Moringa oleifera L. Extract on leydig and sertoli cells induced high Temperature on Rattus norvegicus. Res J Pharm Technol. 2020; 13: 3361. https://doi.org/10.5958/0974-360X.2020.00597.1.
13. Kokate C. K., Purohit A.P. A Text Book of Practical Pharmacognosy. Vol. 5. Vallabh Prakashan; 2005.
14. Harborne J.B. Textbook of Phytochemical Methods. A Guide to Modern Techniques of Plant Analysis. 5th ed. London: Chapman and Hall Ltd; 1998.
15. Ramachandran V, Kumar GV, Sugumar S, Sundaram V, Ahamed HN. Cardioprotective effect of Tridax procumbens Linn in Isoproterenol Induced Myocardial Infarction in rats. Res J Pharm Technol. 2020; 13: 1923. https://doi.org/10.5958/0974-360X.2020.00346.7.
16. Manohar HD, Srinivasan D, Sengottuvelu S. Cardioprotective activity of Limonia acidissima against Isoproterenol Induced Myocardial Infarction in Rats. Res J Pharm Technol. 2016; 9: 541. https://doi.org/10.5958/0974-360X.2016.00102.5.
17. Hardik Joshi, Manoj Pagare, Leena Patil, Vilasrao Kadam. Cardioprotective Effect of Ethanolic Extract of Buchanania lanzan Spreng. Against Isoproterenol Induced Myocardial Infarction in Rats: A Biochemical, Electrocardiographic Evaluation. Res J Pharm Technol. 2012; 5: 263–6.
18. Yasmeen R, Reddy NK, Souza MarinaGD, Swathi B, Waheed AA, Chinmayee K, et al. Study of Anticoagulants low molecular weight heparin and Unfractionated heparin in the management of Non-St elevation Myocardial Infarction. Res J Pharm Technol. 2020; 13: 3151. https://doi.org/10.5958/0974-360X.2020.00557.0.
19. Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiol. 2020; 5: 540. https://doi.org/10.1001/jamacardio.2020.0013.
20. Doha M, Hoda M, Sherein A, Hagar E. Cardioprotective potency of anthocyanin-rich extract of red cabbage against isoproterenol-induced myocardial infarction in experimental animals. J Appl Pharm Sci. 2021. https://doi.org/10.7324/JAPS.2021.110804.
21. Manohar HD, Srinivasan D, Sengottuvelu S. Cardioprotective activity of Limonia acidissima against Isoproterenol Induced Myocardial Infarction in Rats. Res J Pharm Technol. 2016; 9: 541. https://doi.org/10.5958/0974-360X.2016.00102.5.
22. Singh KD, Singh V, Singh A, Kesharwani V. Evaluation of Oxidative Stress potential of some Nsaıds against Hydrogen Peroxide in experimental animal. Res J Pharm Technol. 2021: 6194–200. https://doi.org/10.52711/0974-360X.2021.01072.
23. Khare P, Kishore K, Sharma DK. Catalase and Superoxide Dismutase (SOD) activity in Swiss Albino mice treated with Ethanolic leaf extract of Bauhinia variegata. Res J Pharm Technol. 2019;12:4259. https://doi.org/10.5958/0974-360X.2019.00732.7.
24. Devasagayam TPA, Tarachand U. Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun. 1987;145:134–8. https://doi.org/10.1016/0006-291X(87)91297-6.
25. Bhat IUH, Bhat R. Quercetin: A Bioactive Compound Imparting Cardiovascular and Neuroprotective Benefits: Scope for Exploring Fresh Produce, Their Wastes, and By-Products. Biology (Basel). 2021; 10: 586. https://doi.org/10.3390/biology10070586.
26. Zhou M, Ren H, Han J, Wang W, Zheng Q, Wang D. Protective Effects of Kaempferol against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart via Antioxidant Activity and Inhibition of Glycogen Synthase Kinase-3. Oxid Med Cell Longev. 2015; 2015: 1–8. https://doi.org/10.1155/2015/481405.
27. Al-Numair KS, Veeramani C, Alsaif MA, Chandramohan G. Influence of kaempferol, a flavonoid compound, on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharm Biol. 2015; 53: 1372–8. https://doi.org/10.3109/13880209.2014.982301.
28. Vishwakarma A, Singh TU, Rungsung S, Kumar T, Kandasamy A, Parida S, et al. Effect of Kaempferol Pretreatment on Myocardial Injury in Rats. Cardiovasc Toxicol. 2018; 18: 312–28. https://doi.org/10.1007/s12012-018-9443-5.
29. Metias EF, Aboelmaaty NM, Hussein AM. Modulation of ECG, Myocardial Oxidative Stress Markers and Connexion 43 Expression by Ascorbic Acid and Ferulic Acid in Isoproterenol-Induced Myocardial Infarction in Rats. Biochemistry and Physiology: Open Access. 2016; 05. https://doi.org/10.4172/2168-9652.1000210.
30. Teodorescu C, Reinier K, Uy-Evanado A, Navarro J, Mariani R, Gunson K, et al. Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rhythm. 2011;8:1562–7. https://doi.org/10.1016/j.hrthm.2011.06.011.
31. Thippeswam BS, Thakker SP, Tubachi S, Kalyani GA, Netra MK, Patil U, et al. Cardioprotective Effect of Cucumis trigonus Roxb on Isoproterenol-Induced Myocardial Infarction in Rat. Am J Pharmacol Toxicol. 2009;4:29–37. https://doi.org/10.3844/ajptsp.2009.29.37.
32. Stanely Mainzen Prince P, Rajakumar S, Dhanasekar K. Protective effects of vanillic acid on electrocardiogram, lipid peroxidation, antioxidants, proinflammatory markers and histopathology in isoproterenol induced cardiotoxic rats. Eur J Pharmacol. 2011; 668: 233–40. https://doi.org/10.1016/j.ejphar.2011.06.053.
33. Rohini A, Agrawal N, Koyani CN, Singh R. Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res. 2010; 61: 269–80. https://doi.org/10.1016/j.phrs.2009.11.012.
34. Salter AM, White DA. Effects of Dietary Fat on Cholesterol Metabolism: Regulation of Plasma LDL Concentrations. Nutr Res Rev. 1996;9:241–57. https://doi.org/10.1079/NRR19960013.
35. Morimoto C, Kiyama A, Kameda K, Ninomiya H, Tsujita T, Okuda H. Mechanism of the stimulatory action of okadaic acid on lipolysis in rat fat cells. J Lipid Res. 2000; 41: 199–204. https://doi.org/10.1016/S0022-2275(20)32053-8.
36. Buring JE, O’Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, et al. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation. 1992;85:22–9. https://doi.org/10.1161/01.CIR.85.1.22.
37. Khalil MdI, Ahmmed I, Ahmed R, Tanvir EM, Afroz R, Paul S, et al. Amelioration of Isoproterenol-Induced Oxidative Damage in Rat Myocardium by Withania somnifera Leaf Extract. Biomed Res Int. 2015; 2015: 1–10. https://doi.org/10.1155/2015/624159.
38. Geetha A, Sankar R, Marar T, Devi CS. Alpha-tocopherol reduces doxorubicin-induced toxicity in rats--histological and biochemical evidences. Indian J Physiol Pharmacol. 1990;34:94–100.
39. Saravanan G, Ponmurugan P, Sathiyavathi M, Vadivukkarasi S, Sengottuvelu S. Cardioprotective activity of Amaranthus viridis Linn: Effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. Int J Cardiol. 2013; 165: 494–8. https://doi.org/10.1016/j.ijcard.2011.09.005.
40. Sabeenafarvin K, Anandan R, Senthilkumar S, Shiny K, Sankar T, Thankappan T. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol Res. 2004;50:231–6. https://doi.org/10.1016/j.phrs.2004.03.004.
41. Zhou R, Xu Q, Zheng P, Yan L, Zheng J, Dai G. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur J Pharmacol. 2008; 586: 244–50. https://doi.org/10.1016/j.ejphar.2008.02.057.
42. Cui X, Gong J, Han H, He L, Teng Y, Tetley T, et al. Relationship between free and total malondialdehyde, a well-established marker of oxidative stress, in various types of human biospecimens. J Thorac Dis. 2018; 10: 3088–197. https://doi.org/10.21037/jtd.2018.05.92.
Received on 24.09.2023 Revised on 20.03.2024 Accepted on 04.07.2024 Published on 24.12.2024 Available online from December 27, 2024 Research J. Pharmacy and Technology. 2024;17(12):5967-5973. DOI: 10.52711/0974-360X.2024.00905 © RJPT All right reserved
|